A 12 Month Double-blind, Randomized, Parallel-group, Placebo-controlled, Multi-center Trial to Investigate the Efficacy and Safety of Vagifem Low Dose (10 mcg 17beta-estradiol Vaginal Tablet) for the Treatment of Postmenopausal Atrophic Vaginitis Symptoms
Phase of Trial: Phase III
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Estradiol (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 02 Dec 2009 According to a Novo Nordisk media release, US FDA approval of vagifem was based on the results of this trial.
- 16 Jun 2009 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 25 Nov 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History